Headquartered in Baar, Switzerland, Stallergenes Greer International AG is a global biopharmaceutical company specialising in allergy immunotherapy products and services.
Formed by the merger in 2015 of the two companies that make up its name - the former based in France, the latter in the US - Stallergenes Greer has centres in 21 countries and manufacturing facilities in both Europe and the USA.